Skip Nav Destination
Issues
1 May 2023
EISSN 2573-7732
ON THE HORIZON
Dual TCR-Expressing T Cells in Cancer: How Single-Cell Technologies Enable New Investigation
Immunohorizons (2023) 7 (5): 299–306.
INFECTIOUS DISEASE
Evidence for Aerosol Transfer of SARS-CoV-2–Specific Humoral Immunity
Ross M. Kedl; Elena W. Y. Hsieh; Thomas E. Morrison; Gabriela Samayoa-Reyes; Siobhan Flaherty; Conner L. Jackson; Rosemary Rochford
Immunohorizons (2023) 7 (5): 307–309.
B Cell Chronic Lymphocytic Leukemia Development in Mice with Chronic Lung Exposure to Coccidioides Fungal Arthroconidia
Immunohorizons (2023) 7 (5): 333–352.
CD8+ Regulatory T Cells Induced by Lipopolysaccharide Improve Mouse Endotoxin Shock
Nanaka Morita; Masato Hoshi; Hiroyuki Tezuka; Tatsuya Ando; Sayaka Yoshida; Fumiaki Sato; Hiroyuki Yokoi; Hiroyasu Ito; Kuniaki Saito
Immunohorizons (2023) 7 (5): 353–363.
CLINICAL AND TRANSLATIONAL IMMUNOLOGY
The Plasma Cell Infiltrate Populating the Muscle Tissue of Patients with Inclusion Body Myositis Features Distinct B Cell Receptor Repertoire Properties
Roy Jiang; Bhaskar Roy; Qian Wu; Subhasis Mohanty; Richard J. Nowak; Albert C. Shaw; Steven H. Kleinstein; Kevin C. O’Connor
Immunohorizons (2023) 7 (5): 310–322.
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties
Michael C. Warren; Stephan Matissek; Matthew Rausch; Marisella Panduro; R. J. Hall; Austin Dulak; David Brennan; Sonia Das Yekkirala; Secil Koseoglu; Ricard Masia; Yu Yang; Navamallika Reddy; Robert Prenovitz; Jamie Strand; Tauqueer Zaidi; Erik Devereaux; Célia Jacoberger Foissac; John Stagg; Benjamin H. Lee; Pamela Holland; Vito J. Palombella; Andrew C. Lake
Immunohorizons (2023) 7 (5): 366–379.
EDITORIAL
-
Cover Image
Cover Image
![issue cover]()
- PDF Icon PDF LinkEditorial Board
